Transforming clinical trials in rheumatology: towards patient-centric precision medicine
出版年份 2020 全文链接
标题
Transforming clinical trials in rheumatology: towards patient-centric precision medicine
作者
关键词
-
出版物
Nature Reviews Rheumatology
Volume 16, Issue 10, Pages 590-599
出版商
Springer Science and Business Media LLC
发表日期
2020-09-04
DOI
10.1038/s41584-020-0491-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?
- (2020) Paul Studenic et al. ANNALS OF THE RHEUMATIC DISEASES
- Validity of a two-component imaging-derived disease activity score for improved assessment of synovitis in early rheumatoid arthritis
- (2019) Elizabeth M A Hensor et al. RHEUMATOLOGY
- Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group
- (2019) Tim Pickles et al. JOURNAL OF RHEUMATOLOGY
- Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
- (2019) Frances Humby et al. ANNALS OF THE RHEUMATIC DISEASES
- Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
- (2019) Fan Zhang et al. NATURE IMMUNOLOGY
- Towards Defining Primary and Secondary Non-Response in Rheumatoid Arthritis Patients Treated with Anti-TNFs: Results from the BioTRAC and OBRI Registries
- (2019) Edward Keystone et al. JOURNAL OF RHEUMATOLOGY
- Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
- (2019) Myles J. Lewis et al. Cell Reports
- Synovial tissue signatures enhance clinical classification and prognostic/treatment response algorithms in early inflammatory arthritis and predict requirement for subsequent biological therapy: results from the pathobiology of early arthritis cohort (PEAC)
- (2019) Gloria Lliso-Ribera et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy of acetaminophen with and without oxycodone for analgesia in non-operative treatment of extremity fractures in adults: protocol for a double-blind randomized clinical trial
- (2019) Tao Gao et al. Trials
- Precision medicine using different biological DMARDs based on characteristic phenotypes of peripheral T helper cells in psoriatic arthritis
- (2018) Ippei Miyagawa et al. RHEUMATOLOGY
- Transcriptional Profiling of Synovial Macrophages Using Minimally Invasive Ultrasound-Guided Synovial Biopsies in Rheumatoid Arthritis
- (2018) Arthur M. Mandelin et al. Arthritis & Rheumatology
- Rheumatoid arthritis
- (2018) Josef S. Smolen et al. Nature Reviews Disease Primers
- Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
- (2018) Dominique Baeten et al. ANNALS OF THE RHEUMATIC DISEASES
- Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
- (2018) Atul Deodhar et al. Arthritis & Rheumatology
- Effects of B-cell directed therapy on the preclinical stage of rheumatoid arthritis: the PRAIRI study
- (2018) Danielle M Gerlag et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-6 inhibitor for the treatment of rheumatoid arthritis: A comprehensive review
- (2018) Atsushi Ogata et al. Modern Rheumatology
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study
- (2017) Francisco J. Blanco et al. Arthritis & Rheumatology
- Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study
- (2016) Brigitte Michelsen et al. ANNALS OF THE RHEUMATIC DISEASES
- Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis: Table 1
- (2016) Mira Merashli et al. ANNALS OF THE RHEUMATIC DISEASES
- Tumour necrosis factor inhibition versus rituximab for patients with rheumatoid arthritis who require biological treatment (ORBIT): an open-label, randomised controlled, non-inferiority, trial
- (2016) Duncan Porter et al. LANCET
- Head-to-head comparison of certolizumab pegol versus adalimumab in rheumatoid arthritis: 2-year efficacy and safety results from the randomised EXXELERATE study
- (2016) Josef S Smolen et al. LANCET
- Rheumatoid arthritis
- (2016) Josef S Smolen et al. LANCET
- Stratified medicine in rheumatoid arthritis—the MATURA programme
- (2016) Anne Barton et al. RHEUMATOLOGY
- Review of head-to-head study designs in rheumatoid arthritis
- (2016) Fleischmann R. et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Generalizability of Patients With Rheumatoid Arthritis in Biologic Agent Clinical Trials
- (2016) Priyanka Vashisht et al. ARTHRITIS CARE & RESEARCH
- The Efficacy and Safety of Clazakizumab, an Anti-Interleukin-6 Monoclonal Antibody, in a Phase IIb Study of Adults With Active Psoriatic Arthritis
- (2016) Philip J. Mease et al. Arthritis & Rheumatology
- Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
- (2016) Miranta Antoniou et al. PLoS One
- Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study
- (2015) Kanta Kumar et al. BMC MUSCULOSKELETAL DISORDERS
- Patient-centric trials for therapeutic development in precision oncology
- (2015) Andrew V. Biankin et al. NATURE
- Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
- (2015) Josef S. Smolen et al. Nature Reviews Rheumatology
- Personalized biological treatment for rheumatoid arthritis: a systematic review with a focus on clinical applicability
- (2015) Bart V. J. Cuppen et al. RHEUMATOLOGY
- Ectopic lymphoid neogenesis is strongly associated with activation of the IL-23 pathway in rheumatoid synovitis
- (2015) Juan D. Cañete et al. ARTHRITIS RESEARCH & THERAPY
- Use of Ultrasound-Guided Small Joint Biopsy to Evaluate the Histopathologic Response to Rheumatoid Arthritis Therapy: Recommendations for Application to Clinical Trials
- (2015) Frances Humby et al. Arthritis & Rheumatology
- Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS)
- (2014) Denis Poddubnyy et al. ANNALS OF THE RHEUMATIC DISEASES
- Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics
- (2014) Glynn Dennis et al. ARTHRITIS RESEARCH & THERAPY
- Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomised, placebo-controlled trials
- (2013) Joachim Sieper et al. ANNALS OF THE RHEUMATIC DISEASES
- Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patients
- (2013) S Kelly et al. ANNALS OF THE RHEUMATIC DISEASES
- Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study
- (2013) Yoshiya Tanaka et al. ANNALS OF THE RHEUMATIC DISEASES
- New learnings on the pathophysiology of RA from synovial biopsies
- (2013) Costantino Pitzalis et al. CURRENT OPINION IN RHEUMATOLOGY
- Creative trial design in RA: optimizing patient outcomes
- (2013) Maya H. Buch et al. Nature Reviews Rheumatology
- The problem of choice: current biologic agents and future prospects in RA
- (2013) Ernest H. Choy et al. Nature Reviews Rheumatology
- Global Molecular Effects of Tocilizumab Therapy in Rheumatoid Arthritis Synovium
- (2013) Julie Ducreux et al. Arthritis & Rheumatology
- Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis
- (2012) John D Isaacs et al. ANNALS OF THE RHEUMATIC DISEASES
- Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
- (2012) Saba Alzabin et al. ANNALS OF THE RHEUMATIC DISEASES
- Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab
- (2012) Vanessa E Hogan et al. ANNALS OF THE RHEUMATIC DISEASES
- Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study
- (2012) Michael E. Weinblatt et al. ARTHRITIS AND RHEUMATISM
- Rituximab treatment induces the expression of genes involved in healing processes in the rheumatoid arthritis synovium
- (2011) I. Gutierrez-Roelens et al. ARTHRITIS AND RHEUMATISM
- A personalized medicine approach to biologic treatment of rheumatoid arthritis: a preliminary treatment algorithm
- (2011) P. P. Tak RHEUMATOLOGY
- Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis
- (2010) G. Schett et al. ANNALS OF THE RHEUMATIC DISEASES
- Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis
- (2009) Valérie Badot et al. ARTHRITIS RESEARCH & THERAPY
- The value of synovial cytokine expression in predicting the clinical response to TNF antagonist therapy (infliximab)
- (2008) M. H. Buch et al. RHEUMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started